Review: doxorubicin delivery systems based on chitosan for cancer therapy

Objectives This review sheds insight into an increasingly popular polymer that has been widely explored as a potential drug delivery system. The abundant, biodegradable and biocompatible polysaccharide chitosan, with many other favourable properties, has been favoured as a drug delivery system for the purposes of encapsulating and delivery of doxorubicin with reduced side‐effects.

[1]  P. Choong,et al.  Involvement of c-jun in human liposarcoma growth: supporting data from clinical immunohistochemistry and DNAzyme efficacy , 2008, Cancer biology & therapy.

[2]  P. Choong,et al.  c-Jun knockdown sensitizes osteosarcoma to doxorubicin , 2008, Molecular Cancer Therapeutics.

[3]  P. Choong,et al.  Downregulation of c-jun results in apoptosis-mediated anti-osteosarcoma activity in an orthotopic model , 2008, Cancer biology & therapy.

[4]  Y. Maitani,et al.  In vivo antitumor activity of camptothecin incorporated in liposomes formulated with an artificial lipid and human serum albumin. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[5]  Hong Yuan,et al.  Cellular uptake and cytotoxicity of shell crosslinked stearic acid-grafted chitosan oligosaccharide micelles encapsulating doxorubicin. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[6]  E. Kang,et al.  Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy. , 2008, Biomaterials.

[7]  Hong Yuan,et al.  Core-modified chitosan-based polymeric micelles for controlled release of doxorubicin. , 2008, International journal of pharmaceutics.

[8]  C. Kaittanis,et al.  Dextran-coated gold nanoparticles for the assessment of antimicrobial susceptibility. , 2008, Analytical chemistry.

[9]  P. Cullis,et al.  Liposomal nanomedicines , 2008, Expert opinion on drug delivery.

[10]  Jing Zhang,et al.  Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin. , 2007, Nanomedicine : nanotechnology, biology, and medicine.

[11]  Claus-Michael Lehr,et al.  Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. , 2007, Nanomedicine : nanotechnology, biology, and medicine.

[12]  Chao-Liang Wu,et al.  Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model. , 2007, Molecular pharmaceutics.

[13]  M. Michaelis,et al.  Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles. , 2007, International journal of pharmaceutics.

[14]  S. Ferrari,et al.  Long-term follow-up of patients with doxorubicin-induced cardiac toxicity after chemotherapy for osteosarcoma , 2007, Anti-cancer drugs.

[15]  G. Scambia,et al.  Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia ('hand-foot' syndrome). , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  P. Choong,et al.  Chitosan microparticles encapsulating PEDF plasmid demonstrate efficacy in an orthotopic metastatic model of osteosarcoma. , 2007, Biomaterials.

[17]  Jianfeng Chen,et al.  Formulation and cytotoxicity of doxorubicin loaded in self-assembled bio-polyelectrolyte microshells. , 2007, International journal of pharmaceutics.

[18]  U. Kompella,et al.  Human serum albumin nanoparticles for efficient delivery of Cu, Zn superoxide dismutase gene , 2007, Molecular vision.

[19]  Qi Zhou,et al.  Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system. , 2007, Cancer research.

[20]  M. Sastry,et al.  Chitosan Reduced Gold Nanoparticles as Novel Carriers for Transmucosal Delivery of Insulin , 2007, Pharmaceutical Research.

[21]  E. Simanek,et al.  Dendrimers as drug delivery vehicles: non-covalent interactions of bioactive compounds with dendrimers. , 2007, Polymer international.

[22]  Changyou Gao,et al.  Hollow chitosan-alginate multilayer microcapsules as drug delivery vehicle: doxorubicin loading and in vitro and in vivo studies. , 2007, Nanomedicine : nanotechnology, biology, and medicine.

[23]  Yong Hu,et al.  Hollow chitosan/poly(acrylic acid) nanospheres as drug carriers. , 2007, Biomacromolecules.

[24]  P. Cullis,et al.  Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN , 2007, Cancer Immunology, Immunotherapy.

[25]  Yan Li,et al.  Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: results of an in vitro and in vivo study. , 2007, Life sciences.

[26]  B. Kwak,et al.  Preparation of doxorubicin-containing chitosan microspheres for transcatheter arterial chemoembolization of hepatocellular carcinoma , 2007, Journal of microencapsulation.

[27]  E. W. Meijer,et al.  Dendrimeric poly(propylene-imines) as effective delivery agents for DNAzymes: dendrimer synthesis, stability and oligonucleotide complexation. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[28]  E. W. Meijer,et al.  Dendrimeric poly(propylene-imines) as effective delivery agents for DNAzymes: toxicity, in vitro transfection and in vivo delivery. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[29]  T. Fujieda,et al.  Feasibility of simple chitosan sheet as drug delivery carrier. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[30]  R. Zhuo,et al.  Thermosensitive Y-shaped micelles of poly(oleic acid-Y-N-isopropylacrylamide) for drug delivery. , 2006, Small.

[31]  S. Lipshultz.  Exposure to anthracyclines during childhood causes cardiac injury. , 2006, Seminars in oncology.

[32]  John C. Bischof,et al.  Enhancement of tumor thermal therapy using gold nanoparticle–assisted tumor necrosis factor-α delivery , 2006, Molecular Cancer Therapeutics.

[33]  M. Sastry,et al.  Gold nanoparticles as carriers for efficient transmucosal insulin delivery. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[34]  R. Duncan,et al.  Dendrimer biocompatibility and toxicity. , 2005, Advanced drug delivery reviews.

[35]  R. Shukla,et al.  Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[36]  C. Wolf,et al.  The role of bioreductive activation of doxorubicin in cytotoxic activity against leukaemia HL60-sensitive cell line and its multidrug-resistant sublines , 2005, British Journal of Cancer.

[37]  You Han Bae,et al.  Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[38]  K. Ulbrich,et al.  Polymeric micellar pH-sensitive drug delivery system for doxorubicin. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[39]  Youngseon Choi,et al.  Targeting Cancer Cells with DNA-Assembled Dendrimers: A Mix-and-Match Strategy for Cancer , 2005, Cell cycle.

[40]  A. C. Hunter,et al.  Nanomedicine: current status and future prospects , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  J. Lee,et al.  Therapeutic Effects of Holmium-166 Chitosan Complex in Rat Brain Tumor Model , 2005, Yonsei medical journal.

[42]  K. Strebhardt,et al.  Highly Specific HER2-mediated Cellular Uptake of Antibody-modified Nanoparticles in Tumour Cells , 2004, Journal of drug targeting.

[43]  Lars Dähne,et al.  Tailor-made polyelectrolyte microcapsules: from multilayers to smart containers. , 2004, Angewandte Chemie.

[44]  H. Caron,et al.  Anthracycline cardiotoxicity in children. , 2004, The New England journal of medicine.

[45]  P. Merlet,et al.  Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy , 2004, British Journal of Cancer.

[46]  Levon M Khachigian,et al.  Inhibition of human breast carcinoma proliferation, migration, chemoinvasion and solid tumour growth by DNAzymes targeting the zinc finger transcription factor EGR-1. , 2004, Nucleic acids research.

[47]  D. Astruc,et al.  Gold Nanoparticles: Assembly, Supramolecular Chemistry, Quantum‐Size‐Related Properties, and Applications Toward Biology, Catalysis, and Nanotechnology. , 2004 .

[48]  A. Santoro,et al.  Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[49]  A. Bozkır,et al.  Chitosan Nanoparticles for Plasmid DNA Delivery: Effect of Chitosan Molecular Structure on Formulation and Release Characteristics , 2004, Drug delivery.

[50]  I. Kwon,et al.  Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[51]  Mansoor Amiji,et al.  Chitosan-based gastrointestinal delivery systems. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[52]  G. Levitt,et al.  Late anthracycline cardiotoxicity after childhood cancer , 2003, Cancer.

[53]  M. Burton,et al.  Modified microplex vector enhances transfection of cells in culture while maintaining tumour‐selective gene delivery in‐vivo , 2003, The Journal of pharmacy and pharmacology.

[54]  Sha Li,et al.  Studies on alginate-chitosan microcapsules and renal arterial embolization in rabbits. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[55]  Hui Xu,et al.  Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. , 2002, International journal of pharmaceutics.

[56]  Yang Li,et al.  Cellular uptake, distribution, and stability of 10-23 deoxyribozymes. , 2002, Antisense & nucleic acid drug development.

[57]  P. Couvreur,et al.  Nanoparticles in cancer therapy and diagnosis. , 2002, Advanced drug delivery reviews.

[58]  Jia-cong Shen,et al.  Spontaneous deposition of horseradish peroxidase into polyelectrolyte multilayer capsules to improve its activity and stability. , 2002, Chemical communications.

[59]  M. Burton,et al.  Liposomes Containing Cationic Dimethyl Dioctadecyl Ammonium Bromide: Formulation, Quality Control, and Lipofection Efficiency , 2002, Drug delivery.

[60]  A. Maitra,et al.  Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[61]  K. Janes,et al.  Chitosan nanoparticles as delivery systems for doxorubicin. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[62]  S. Neau,et al.  In vitro degradation of chitosan by a commercial enzyme preparation: effect of molecular weight and degree of deacetylation. , 2001, Biomaterials.

[63]  M. Hirai,et al.  Chitosan Induces Apoptosis via Caspase‐3 Activation in Bladder Tumor Cells , 2001, Japanese journal of cancer research : Gann.

[64]  M. Akashi,et al.  Design of nanoparticles composed of graft copolymers for oral peptide delivery. , 2001, Advanced drug delivery reviews.

[65]  G. Batist,et al.  Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[66]  Y Wang,et al.  Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[67]  C. Dass,et al.  Particle-Mediated Intravascular Delivery of Oligonucleotides to Tumors: Associated Biology and Lessons from Genotherapy , 2001, Drug delivery.

[68]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[69]  M. Burton,et al.  Microsphere-Mediated Targeted Gene Therapy of Solid Tumors , 1999 .

[70]  M. Newman,et al.  Reduction of the cardiotoxicity of doxorubicin in rabbits and dogs by encapsulation in long-circulating, pegylated liposomes. , 1999, The Journal of pharmacology and experimental therapeutics.

[71]  Gero Decher,et al.  Fuzzy Nanoassemblies: Toward Layered Polymeric Multicomposites , 1997 .

[72]  D. Lasič,et al.  Doxorubicin in sterically stabilized liposomes , 1996, Nature.

[73]  Lisbeth Illum,et al.  Chitosan as a Novel Nasal Delivery System for Peptide Drugs , 1994, Pharmaceutical Research.

[74]  T. Perren.  The Cytotoxics Handbook , 1991, British Journal of Cancer.

[75]  M. Yatvin,et al.  pH-sensitive liposomes: possible clinical implications. , 1980, Science.

[76]  C. Dass.  Drug delivery in cancer using liposomes. , 2008, Methods in molecular biology.

[77]  P. Choong,et al.  Osteosarcoma progression requires c-jun , 2008 .

[78]  T. Xu,et al.  Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery. , 2008, Frontiers in bioscience : a journal and virtual library.

[79]  Zi-rong Xu,et al.  In vitro and in vivo suppression of hepatocellular carcinoma growth by chitosan nanoparticles. , 2007, European journal of cancer.

[80]  Ick Chan Kwon,et al.  Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity. , 2006, Biomaterials.

[81]  L. Kabasakal,et al.  Co-encapsulation of two plasmids in chitosan microspheres as a non-viral gene delivery vehicle. , 2003, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[82]  Y. Machida,et al.  Biodegradation and distribution of water-soluble chitosan in mice. , 1999, Biomaterials.

[83]  M. Burton,et al.  A Microsphere-Lipoplex (Microplex) Vector for Targeted Gene Therapy of Cancer. I. Construction and In Vitro Evaluation , 1999 .

[84]  J. Karlsen,et al.  EXCIPIENT PROPERTIES OF CHITOSAN , 1991 .

[85]  T. Chandy,et al.  Chitosan--as a biomaterial. , 1990, Biomaterials, artificial cells, and artificial organs.

[86]  W. Jungi.  [Bone and soft tissue sarcomas]. , 1978, Schweizerische medizinische Wochenschrift.